Victoria Meucci Villaflor, James J. Harding, Daruka Mahadevan, Manish R. Sharma, Alexander G. Raufi, Jason Timothy Henry, Il-Hwan Kim, Chang-Fang Chiu, Yan Xing, Akosua Badu-Nkansah, Martha Elizabeth Blaney, Rui Li, Manal Mehibel, Anna Shurshalina, Marjilla Seddiq, Mohammad Alshaer, Michael Charles Burns, David S. Hong. "Phase 1 basket study of telisotuzumab adizutecan (Temab-A, ABBV-400), a c-Met protein–targeting antibody-drug conjugate: Results from patients with head and neck squamous cell carcinoma (HNSCC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.6027